Related references
Note: Only part of the references are listed.Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge
Julie Quessada et al.
GENES (2021)
High Frequency of Fusion Gene Transcript Resulting From t(10;11)(p12;q23) Translocation in Pediatric Acute Myeloid Leukemia in Poland
Teofila Ksiazek et al.
FRONTIERS IN PEDIATRICS (2020)
Improved Outcome in Pediatric AML - the AML-BFM 2012 Study
Katharina Waack et al.
BLOOD (2020)
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
Jing Chen et al.
CHILDREN-BASEL (2020)
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Mari Wilhelmsson et al.
BONE MARROW TRANSPLANTATION (2019)
A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia
C. Michel Zwaan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia
Naghmeh Niktoreh et al.
JOURNAL OF ONCOLOGY (2019)
Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era
Erin E. Doherty et al.
BLOOD (2019)
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
Mareike Rasche et al.
LEUKEMIA (2018)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial
K. Bochennek et al.
BLOOD CANCER JOURNAL (2016)
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
C. Michel Zwaan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study
F. Locatelli et al.
BONE MARROW TRANSPLANTATION (2015)
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group
Katherine Tarlock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004
Ursula Creutzig et al.
BLOOD (2013)
Development of treatment and clinical results in childhood acute myeloid leukemia in Poland
Walentyna Balwierz et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2013)
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
Ursula Creutzig et al.
BLOOD (2012)
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant
K. Ishiyama et al.
LEUKEMIA (2012)
Improved outcome in pediatric AML due to augmented supportive care
Wasil Jastaniah et al.
PEDIATRIC BLOOD & CANCER (2012)
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)
Ursula Creutzig et al.
BLOOD (2011)
Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
Christine von Neuhoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
Christine J. Harrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
Brian V. Balgobind et al.
BLOOD (2009)
The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)
David R. Betts et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi et al.
BLOOD (2006)
Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia
A Dluzniewska et al.
LEUKEMIA (2005)
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93
T Lehrnbecher et al.
LEUKEMIA (2004)
Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98
U Creutzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience
JE Rubnitz et al.
LEUKEMIA (2002)
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone:: Results of study Acute Myeloid Leukemia -: Berlin-Frankfurt-Munster 93
U Creutzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Idarubicin improves blast cell clearance during induction therapy in children with AML:: results of study AML-BFM 93
U Creutzig et al.
LEUKEMIA (2001)
Share Paper
